Crystallization and 1.1-A diffraction of chorismate lyase from Escherichia coli.

Article Details

Citation

Stover C, Mayhew MP, Holden MJ, Howard A, Gallagher DT

Crystallization and 1.1-A diffraction of chorismate lyase from Escherichia coli.

J Struct Biol. 2000 Feb;129(1):96-9.

PubMed ID
10675300 [ View in PubMed
]
Abstract

Chorismate pathway enzymes are important as producers of nonnucleotide aromatic compounds. The enzyme chorismate lyase from Escherichia coli has been crystallized in four distinct forms, three of which have been characterized by X-ray diffraction. Despite widespread screening, all four crystal forms grow from the same chemical conditions. The wild-type enzyme tends to aggregate, even in the presence of reducing agent, and yielded only one crystal form (monoclinic, form 1) that grew in intricate clusters. Chemical modification of the cysteines mitigated problems with aggregation and solubility but did not affect crystal growth behavior. Protein aggregation was largely eliminated by mutating the protein's two cysteines to serines. The double mutant retains full enzymatic activity and crystallizes in three new forms, one of which (triclinic) diffracts to 1.1-A resolution.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Chorismate pyruvate-lyaseP26602Details